Parnell Pharmaceuticals Holding (PARN) 4.19

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:10 PM

Parnell Pharmaceuticals Holding (PARN) 4.19 $PARN

Parnell Pharmaceuticals' (PARN) CEO Robert Joseph on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 3:11PM CDT

PARN: 4.19 (-0.30)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:45AM CDT

AEC: 28.49 (+4.01), SMCI: 31.90 (-2.91), CAMP: 20.87 (+4.19), GEVO: 2.79 (+0.78), DSKX: 1.64 (+0.30), CCIH: 14.86 (+2.54), ENZN: 1.70 (+0.20), NRP: 5.54 (-1.38), PARN: 4.19 (-0.30), GBSN: 4.98 (+1.44), AMSC: 10.40 (+1.20), PW: 6.33 (-2.95), EARS: 4.65 (-0.75), EMMS: 1.61 (-0.24), COOL: 1.40 (-0.21), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), HMNY: 2.90 (-0.63), PKT: 11.42 (+1.91), ZHNE: 1.89 (+0.36)

Parnell Pharma Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 7:28AM CDT

PARN: 4.19 (-0.30)

Parnell Pharma reports Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:03AM CDT

PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results
GlobeNewswire - Wed Apr 22, 6:00AM CDT
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced business results for the first quarter 2015.
PARN: 4.19 (-0.30)

Parnell to Discuss First Quarter Business Performance on April 22, 2015
GlobeNewswire - Mon Apr 13, 3:56PM CDT
Parnell Pharmaceuticals Holdings Ltd. (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that the Company will report first quarter business results on April 22, 2015. As a Foreign Private Issuer, Parnell is only required to report financial results each half-year. Going forward, the Company intends to provide quarterly updates to investors for the interim quarters.
PARN: 4.19 (-0.30)

Will Parnell Pharmaceuticals (PARN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 8:14AM CDT
Will Parnell Pharmaceuticals (PARN) Continue to Surge Higher?
PARN: 4.19 (-0.30)

Strength Seen in Parnell (PARN): Stock Rises 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 8:25AM CDT
Parnell (PARN) was a big mover last session, with shares rising just over 9% on the day.
PARN: 4.19 (-0.30), AKRX: 53.70 (-1.69)

Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit
GlobeNewswire - Mon Mar 09, 4:00PM CDT
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will be presenting at the Jefferies 2015 Animal Health Summit in New York on Thursday, March 26, 2015 at 11:40 AM ET.
PARN: 4.19 (-0.30)

Parnell to Report Financial Results for the Fiscal Period Ended December 31, 2014 on February 25, 2015
GlobeNewswire - Thu Feb 12, 9:11PM CST
Parnell Pharmaceuticals Holdings Ltd. (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, announced today that on February 25, 2015 at 7:00 am ET it will report financial results for the six-month period ended December 31, 2014. The six-month reporting period is part of a previously announced transition to reporting financial results on a calendar year basis (previously June 30 year-end).
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference
GlobeNewswire - Mon Jan 12, 6:40PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will be presenting at the Biotech Showcase Conference in San Francisco on Tuesday, January 13, 2015 at 9:30 AM PST.
PARN: 4.19 (-0.30)

Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:25AM CST
Parnell (PARN) was a big mover last session, with shares rising over 5% on the day.
PARN: 4.19 (-0.30), AKRX: 53.70 (-1.69)

Parnell Management Adopts 10b5-1 Trading Plans
GlobeNewswire - Fri Dec 19, 2:00PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, reported today that Robert Joseph, President and Chief Executive Offer, and Brad McCarthy, Chief Financial Officer, have each adopted a prearranged trading plan effective December 15, 2014 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and Parnell policy. The 10b5-1 plans call for the personal purchase of shares of company stock by Mr. Joseph and Mr. McCarthy in market transactions which commenced on December 17, 2014.
PARN: 4.19 (-0.30)

Parnell Announces Key Senior Management and Director Appointments
GlobeNewswire - Tue Dec 09, 4:50PM CST
Parnell Pharmaceuticals Holdings Ltd., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced the appointments of Edward Robb, DVM as Chief Scientific Officer, Andy Ferrigno as Vice President of Global Sales and Thomas E. Duley as a member of the Board of Directors and member of the Audit Committee. Dr. Robb brings significant R&D, clinical research and product development expertise in companion and production animal veterinary medicine to Parnell. Mr. Ferrigno joins with a successful, longstanding track record in animal health sales, having served as Vice President of Sales for the Novartis' US Companion Animal Business. Mr. Duley is a partner in King & Spaulding's Silicon Valley Corporate Practice Group and has extensive experience in Life Science industry strategic partnerships, agreements and transactions.
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End
GlobeNewswire - Tue Dec 09, 4:28PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, reported today that the Company's Board of Directors approved a fiscal year-end change from June 30 to December 31, effective December 8, 2014. This change was made in order to align fiscal reporting with existing management processes which use calendar year planning and to provide more efficient reporting for US investors.
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Nov 12, 3:30PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will present at two upcoming investor conferences:
PARN: 4.19 (-0.30)

Jaguar Animal Health postpones IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 10:57AM CST

IPO: 24.98 (+0.05), JAGX: (), BIS: 30.54 (+0.15), PARN: 4.19 (-0.30), BIB: 177.06 (-0.89), IBB: 363.84 (-0.66)

Parnell Pharmaceuticals Holdings posts higher net loss after tax of AUD17.3m for fiscal 2014
M2 - Tue Sep 16, 6:23AM CDT
Pharmaceutical company Parnell Pharmaceuticals Holdings (NasdaqGM

ARN) on Monday declared a net loss after tax of AUD17.3m for the fiscal year 2014.
PARN: 4.19 (-0.30)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...